JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 39 filers reported holding JUNIPER PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $456,000 | +31.4% | 52,500 | +53.5% | 0.03% | +22.7% |
| Q1 2018 | $347,000 | +114.2% | 34,200 | +2.1% | 0.02% | +144.4% |
| Q4 2017 | $162,000 | -22.1% | 33,485 | -26.9% | 0.01% | -18.2% |
| Q3 2017 | $208,000 | -31.4% | 45,800 | -23.7% | 0.01% | -42.1% |
| Q2 2017 | $303,000 | +41.6% | 60,000 | +33.0% | 0.02% | +35.7% |
| Q1 2017 | $214,000 | -24.1% | 45,100 | -10.7% | 0.01% | -39.1% |
| Q4 2016 | $282,000 | +5.2% | 50,500 | +4.3% | 0.02% | +4.5% |
| Q3 2016 | $268,000 | -11.8% | 48,400 | +11.3% | 0.02% | -21.4% |
| Q2 2016 | $304,000 | -13.6% | 43,500 | -18.5% | 0.03% | -22.2% |
| Q1 2016 | $352,000 | -25.3% | 53,400 | +16.6% | 0.04% | -40.0% |
| Q4 2015 | $471,000 | +2.2% | 45,800 | +16.8% | 0.06% | 0.0% |
| Q3 2015 | $461,000 | +145.2% | 39,200 | +86.7% | 0.06% | +130.8% |
| Q2 2015 | $188,000 | – | 21,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 388,132 | $1,844,000 | 0.38% |
| Krensavage Asset Management, LLC | 243,128 | $1,155,000 | 0.37% |
| ALGERT GLOBAL LLC | 108,315 | $514,000 | 0.14% |
| HEARTLAND ADVISORS INC | 400,000 | $1,900,000 | 0.12% |
| AWM Investment Company, Inc. | 200,000 | $950,000 | 0.09% |
| TFS CAPITAL LLC | 31,619 | $150,000 | 0.05% |
| GLOBEFLEX CAPITAL L P | 20,012 | $95,000 | 0.02% |
| Spark Investment Management LLC | 45,100 | $214,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 180,200 | $856,000 | 0.01% |
| Acrospire Investment Management LLC | 1,605 | $8,000 | 0.01% |